ad image

Regenerative Medicine

1 / 1
Bio-Techne Corporation
Protein Portfolio

Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine

Bio-Techne Corporation

PR-01-25-NI-05Jan 10, 2025
A Novel Technology Platform for Bone Regeneration and Cancer Treatment
Bone Regeneration

A Novel Technology Platform for Bone Regeneration and Cancer Treatment

Denis Dufrane, M.D., Ph.D.

PAO-03-23-CL-06Mar 20, 2023
NFTs Are Bringing the Regenerative Medicine Community Together
Regenerative Medicine

NFTs Are Bringing the Regenerative Medicine Community Together

Danielle Alvarez

Pharma's Almanac

PAO-05-022-CL-07May 23, 2022
Eliminating Immunosuppression in Regenerative Medicine
Regenerative Medicine

Eliminating Immunosuppression in Regenerative Medicine

iTolerance

PAO-04-22-R250-74Apr 29, 2022
Battling Ischemia with Therapeutic Angiogenesis
Ischemia

Battling Ischemia with Therapeutic Angiogenesis

Zhittya Genesis Medicine

PAO-03-22-R250-11Mar 15, 2022
Accelerating Innovation in Regenerative Medicine
Regenerative Medicine

Accelerating Innovation in Regenerative Medicine

RoosterBio

PAO-02-22-R250-04Feb 03, 2022
Enabling Novel Cell Therapies by Leveraging Established Blood Stem Cell Transplant Infrastructure
Cell Therapy

Enabling Novel Cell Therapies by Leveraging Established Blood Stem Cell Transplant Infrastructure

Chris McClain

Be The Match BioTherapies

PAO-09-21-CL-04Sep 09, 2021
Krystal Biotech
Clinical Trials

Krystal Biotech Announces Positive Results from Phase 2 Clinical Trial and Receives Regenerative Medicine Advanced Therapy Designation

Krystal Biotech

PR-M06-19-NI-047Jun 25, 2019
Exploring the Efficacy of Stem Cells in Reversing Age-Related Frailty
Stem Cell Therapy

Exploring the Efficacy of Stem Cells in Reversing Age-Related Frailty

Geoff Green

Longeveron

PAP-Q2-2019-CL-023May 24, 2019
U.S. Food & Drug Administration
FDA

FDA Advances New Efforts to Promote Development of Safe and Effective Regenerative Medicine Products

U.S. Food & Drug Administration

PR-M02-19-NI-037Feb 19, 2019
Zen Care
Regenerative Medicine Therapies

Affordable Regenerative Stem Cell Therapy is Now Offered Through Zen Care Physical Medicine in Irvine at an Extraordinary Value

Zen Care

PR-M08-18-NI-094Aug 23, 2018
Cytotheryx
Regenerative Medicine Therapies

Ambys Medicines Launches with $140 Million to Pioneer Regenerative Medicine Therapies for Serious Liver Diseases

Cytotheryx

PR-M08-18-NI-079Aug 20, 2018
International Society for Cellular Therapy Supports New FDA Policy Framework for Regenerative Medicine
Regenerative Medicine

International Society for Cellular Therapy Supports New FDA Policy Framework for Regenerative Medicine

Emilie Branch

Pharma's Almanac

PAO-M12-17-NI-004Dec 01, 2017
1 / 1